김승환

Filings by 김승환 span 3 companies, the busiest being 미래에셋생명, 기아 and 셀트리온제약. Between 12 March 2024 and 1 April 2026, the trades on record add up to 4 filings.

Purchases make up the whole of the open-market record (4 purchases, €92k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 3 purchases and no sales on the market.

The median purchase comes to €28k. As a share of market capitalisation, the median purchase stands at 0.0001%, based on 3 purchases. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -3.5%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 7 April 2026: an open-market purchase of €23k, in 기아. Filings reach the DART (FSS) feed a median of 6 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.